AbbVie · 17 hours ago
Scientist I, Immunosafety
Worcester, MA
Full-time
Onsite
Entry, Mid Level
$73K/yr - $138K/yr
2+ years expAbbVie is dedicated to discovering and delivering innovative medicines and solutions to address serious health issues. The Scientist I in Immunosafety will evaluate the immunosafety risk potential of therapeutic large molecules through in vitro assays, contributing to the development of preclinical molecules.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Execute human cytokine release assays including whole blood- and PBMC- based formats
Conduct complement activation assays, troubleshooting and optimizing as needed
Perform cell subset isolation protocols on human whole blood or PBMC samples
Conduct T cell proliferation assay usings isolated cells
Analyze experimental data and maintain accurate documentation, placing data in proper scientific context through review of relevant literature and reporting findings at team meetings
Qualification
Required
B.S. in Biological Sciences, Cellular Immunology, or related field with typically 5 years of experience, or Master's Degree or equivalent education with typically two years of experience
Understanding of cellular immunology with an emphasis on blood cell subsets and T cell biology
Experience with whole blood-based cell assays, blood cell isolation, and serum cytokine readouts
Experience with multicolor flow cytometry panel design, BD LSRFortessa instrument operation, BD FACSDive and FlowJo software, and flow cytometry data analysis
Excellent interpersonal and oral/written communication skills
Results-oriented work ethic and a positive 'can-do' attitude with a strong sense of urgency and self-motivated desire to achieve common business goals
Demonstrated ability to collaborate effectively in a dynamic, cross-functional matrix environment
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2026-01-23
2026-01-20
2026-01-20
Company data provided by crunchbase